STING AND TLR-Targeted Therapies Summit 2023

Kongressthemen
The field of innate immune target-mediated activation has experienced a dynamic year, with both promising clinical data on the horizon and recent setbacks on the minds of drug developers. In light of these developments, it is an ideal time to bring together the community to discuss the current state of the industry and consider next steps.

Kongressorganizer (PCO)
Hanson Wade

Anmerkungen
Brochure: https://go.evvnt.com/1487132-3?pid=4832

Speakers: Mark Moody, Chief Operating Officer, Activate Therapeutics, Shou-Ching Jaminet, Vice President of Discovery Science, Angiex Inc, and more.

https://go.evvnt.com/1487132-2?pid=4832

Frau Jessica Durston